Masahiro Hata1, Hiroto Kinoshita2, Yoku Hayakawa3, Mitsuru Konishi1, Mayo Tsuboi1, Yukiko Oya1, Ken Kurokawa1, Yuki Hayata1, Hayato Nakagawa1, Keisuke Tateishi1, Hiroaki Fujiwara4, Yoshihiro Hirata5, Daniel L Worthley6, Yuki Muranishi7, Takahisa Furukawa7, Shunsuke Kon8, Hiroyuki Tomita9, Timothy C Wang10, Kazuhiko Koike1. 1. Department of Gastroenterology, Graduate school of Medicine, the University of Tokyo, Tokyo, Japan. 2. Department of Gastroenterology, Graduate school of Medicine, the University of Tokyo, Tokyo, Japan; Department of Gastroenterology, The Institute for Adult Diseases, Asahi-life Foundation, Tokyo, Japan. 3. Department of Gastroenterology, Graduate school of Medicine, the University of Tokyo, Tokyo, Japan. Electronic address: yhayakawa-tky@umin.ac.jp. 4. Department of Gastroenterology, The Institute for Adult Diseases, Asahi-life Foundation, Tokyo, Japan. 5. Division of Advanced Genome Medicine, The Institute of Medical Science, the University of Tokyo, Tokyo, Japan. 6. Cancer Theme, South Australian Health and Medical Research Institute, South Australia, Australia. 7. Laboratory for Molecular and Developmental Biology, Institute for Protein Research, Osaka University, Osaka, Japan. 8. Tokyo University of Science, Division of Development and Aging, Research Institute for Biomedical Sciences, Chiba, Japan. 9. Department of Tumor Pathology, Gifu University Graduate School of Medicine, Gifu, Japan. 10. Division of Digestive and Liver Disease, Department of Medicine, Columbia University, New York, New York.
Abstract
BACKGROUND & AIMS: Gastric chief cells, a mature cell type that secretes digestive enzymes, have been proposed to be the origin of metaplasia and cancer through dedifferentiation or transdifferentiation. However, studies supporting this claim have had technical limitations, including issues with the specificity of chief cell markers and the toxicity of drugs used. We therefore sought to identify genes expressed specifically in chief cells and establish a model to trace these cells. METHODS: We performed transcriptome analysis of Mist1-CreERT-traced cells, with or without chief cell depletion. Gpr30-rtTA mice were generated and crossed to TetO-Cre mice, and lineage tracing was performed after crosses to R26-TdTomato mice. Additional lineage tracing experiments were performed using Mist1-CreERT, Kitl-CreERT, Tff1-Cre, and Tff2-Cre mice crossed to reporter mice. Mice were given high-dose tamoxifen or DMP-777 or were infected with Helicobacter pylori to induce gastric metaplasia. We studied mice that expressed mutant forms of Ras in gastric cells, using TetO-KrasG12D, LSL-KrasG12D, and LSL-HrasG12V mice. We analyzed stomach tissues from GPR30-knockout mice. Mice were given dichloroacetate to inhibit pyruvate dehydrogenase kinase (PDK)-dependent cell competition. RESULTS: We identified GPR30, the G-protein-coupled form of the estrogen receptor, as a cell-specific marker of chief cells in gastric epithelium of mice. Gpr30-rtTA mice crossed to TetO-Cre;R26-TdTomato mice had specific expression of GPR30 in chief cells, with no expression noted in isthmus stem cells or lineage tracing of glands. Expression of mutant Kras in GPR30+ chief cells did not lead to the development of metaplasia or dysplasia but, instead, led to a reduction in labeled numbers of chief cells and a compensatory expansion of neck lineage, which was derived from upper Kitl+ clones. Administration of high-dose tamoxifen, DMP-777, or H pylori decreased the number of labeled chief cells. Chief cells were eliminated from epithelia via GPR30- and PDK-dependent cell competition after metaplastic stimuli, whereas loss of GRP30 or inhibition of PDK activity preserved chief cell numbers and attenuated neck lineage cell expansion. CONCLUSIONS: In tracing studies of mice, we found that most chief cells are lost during metaplasia and therefore are unlikely to contribute to gastric carcinogenesis. Expansion of cells that coexpress neck and chief lineage markers, known as spasmolytic polypeptide-expressing metaplasia, does not occur via dedifferentiation from chief cells but, rather, through a compensatory response from neck progenitors to replace the eliminated chief cells.
BACKGROUND & AIMS: Gastric chief cells, a mature cell type that secretes digestive enzymes, have been proposed to be the origin of metaplasia and cancer through dedifferentiation or transdifferentiation. However, studies supporting this claim have had technical limitations, including issues with the specificity of chief cell markers and the toxicity of drugs used. We therefore sought to identify genes expressed specifically in chief cells and establish a model to trace these cells. METHODS: We performed transcriptome analysis of Mist1-CreERT-traced cells, with or without chief cell depletion. Gpr30-rtTA mice were generated and crossed to TetO-Cre mice, and lineage tracing was performed after crosses to R26-TdTomato mice. Additional lineage tracing experiments were performed using Mist1-CreERT, Kitl-CreERT, Tff1-Cre, and Tff2-Cre mice crossed to reporter mice. Mice were given high-dose tamoxifen or DMP-777 or were infected with Helicobacter pylori to induce gastric metaplasia. We studied mice that expressed mutant forms of Ras in gastric cells, using TetO-KrasG12D, LSL-KrasG12D, and LSL-HrasG12V mice. We analyzed stomach tissues from GPR30-knockout mice. Mice were given dichloroacetate to inhibit pyruvate dehydrogenase kinase (PDK)-dependent cell competition. RESULTS: We identified GPR30, the G-protein-coupled form of the estrogen receptor, as a cell-specific marker of chief cells in gastric epithelium of mice. Gpr30-rtTA mice crossed to TetO-Cre;R26-TdTomato mice had specific expression of GPR30 in chief cells, with no expression noted in isthmus stem cells or lineage tracing of glands. Expression of mutant Kras in GPR30+ chief cells did not lead to the development of metaplasia or dysplasia but, instead, led to a reduction in labeled numbers of chief cells and a compensatory expansion of neck lineage, which was derived from upper Kitl+ clones. Administration of high-dose tamoxifen, DMP-777, or H pylori decreased the number of labeled chief cells. Chief cells were eliminated from epithelia via GPR30- and PDK-dependent cell competition after metaplastic stimuli, whereas loss of GRP30 or inhibition of PDK activity preserved chief cell numbers and attenuated neck lineage cell expansion. CONCLUSIONS: In tracing studies of mice, we found that most chief cells are lost during metaplasia and therefore are unlikely to contribute to gastric carcinogenesis. Expansion of cells that coexpress neck and chief lineage markers, known as spasmolytic polypeptide-expressing metaplasia, does not occur via dedifferentiation from chief cells but, rather, through a compensatory response from neck progenitors to replace the eliminated chief cells.
Authors: Victoria G Ramsey; Jason M Doherty; Christopher C Chen; Thaddeus S Stappenbeck; Stephen F Konieczny; Jason C Mills Journal: Development Date: 2007-01 Impact factor: 6.868
Authors: Michael Sigal; Maria Del Mar Reinés; Stefanie Müllerke; Cornelius Fischer; Marta Kapalczynska; Hilmar Berger; Elvira R M Bakker; Hans-Joachim Mollenkopf; Michael E Rothenberg; Bertram Wiedenmann; Sascha Sauer; Thomas F Meyer Journal: Nat Cell Biol Date: 2019-06-24 Impact factor: 28.824
Authors: Kelley S Yan; Olivier Gevaert; Grace X Y Zheng; Benedict Anchang; Christopher S Probert; Kathryn A Larkin; Paige S Davies; Zhuan-Fen Cheng; John S Kaddis; Arnold Han; Kelly Roelf; Ruben I Calderon; Esther Cynn; Xiaoyi Hu; Komal Mandleywala; Julie Wilhelmy; Sue M Grimes; David C Corney; Stéphane C Boutet; Jessica M Terry; Phillip Belgrader; Solongo B Ziraldo; Tarjei S Mikkelsen; Fengchao Wang; Richard J von Furstenberg; Nicholas R Smith; Parthasarathy Chandrakesan; Randal May; Mary Ann S Chrissy; Rajan Jain; Christine A Cartwright; Joyce C Niland; Young-Kwon Hong; Jill Carrington; David T Breault; Jonathan Epstein; Courtney W Houchen; John P Lynch; Martin G Martin; Sylvia K Plevritis; Christina Curtis; Hanlee P Ji; Linheng Li; Susan J Henning; Melissa H Wong; Calvin J Kuo Journal: Cell Stem Cell Date: 2017-07-06 Impact factor: 24.633
Authors: Samuel Asfaha; Yoku Hayakawa; Ashlesha Muley; Sarah Stokes; Trevor A Graham; Russell E Ericksen; Christoph B Westphalen; Johannes von Burstin; Teresa L Mastracci; Daniel L Worthley; Chandhan Guha; Michael Quante; Anil K Rustgi; Timothy C Wang Journal: Cell Stem Cell Date: 2015-06-04 Impact factor: 25.269
Authors: Yoku Hayakawa; James G Fox; Tamas Gonda; Daniel L Worthley; Sureshkumar Muthupalani; Timothy C Wang Journal: Cancers (Basel) Date: 2013-01-24 Impact factor: 6.639